Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:08 AM
Ignite Modification Date:
2025-12-25 @ 2:08 AM
NCT ID:
NCT02957760
Eligibility Criteria:
Inclusion Criteria:
* Patients of both sexes of at least 45 years of age.
* with social protection
* Presenting CRVO for less than 1 month duration
* With a decrease of visual acuity and with the best corrected visual acuity lower than 6/10 (73 ETDRS letters)
* Signature of informed consent
Exclusion Criteria:
* predictable lack of compliance to the protocol
* monophtalmic patient or any ocular history or condition that could interfere with the study course or results interpretation.
* active systemic disease
* sickle cell disease
* myeloproliferative disease
* myelosuppression
* kidney or liver insufficiency
* ongoing treatment with hydroxycarbamide or anticoagulant
* Pregnancy, breast-feeding, no efficient contraception (for both sexes)
* wish of paternity (for males of al least 45 years of age)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
45 Years
Maximum Age:
80 Years
Study:
NCT02957760
Study Brief:
Protocol Section:
NCT02957760